Quick Answer
RIGEL PHARMACEUTICALS INC reported Total Revenue of $294.28 million for fiscal year 2025.
RIGEL PHARMACEUTICALS INC Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $294.28M | +64.1% |
| 2024 | $179.28M | +53.4% |
| 2023 | $116.88M | -2.8% |
| 2022 | $120.24M | -19.4% |
| 2021 | $149.24M | +37.4% |
| 2020 | $108.62M | +83.2% |
| 2019 | $59.29M | +33.2% |
| 2018 | $44.51M | +892.6% |
| 2017 | $4.48M | -78.0% |
| 2016 | $20.38M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $69.46M | +25.6% | -31.7% |
| June 30, 2025 | $101.69M | +176.0% | +90.7% |
| March 31, 2025 | $53.33M | +80.6% | -3.6% |
| September 30, 2024 | $55.31M | +96.6% | +50.1% |
| June 30, 2024 | $36.84M | +37.0% | +24.7% |
| March 31, 2024 | $29.53M | +13.3% | +5.0% |
| September 30, 2023 | $28.13M | +25.5% | +4.6% |
| June 30, 2023 | $26.89M | -9.8% | +3.1% |
- RIGEL PHARMACEUTICALS INC showed an increase of +64.1% in Total Revenue compared to the prior fiscal year.
- Over the 2016–2025 period, RIGEL PHARMACEUTICALS INC’s total revenue has grown by 1343.8% (from $20.38 million to $294.28 million).
- The most recent figure is from RIGEL PHARMACEUTICALS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 3, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: